Irbeten Dosage & Drug Information

Concise Prescribing Info Bahasa Concise Prescribing Info

Concise Prescribing Info

Contents

Irbesartan

Indications/Uses

Essential HTN.

Dosage/Direction for Use

150 mg once daily, may be increased to 300 mg daily.

Administration

May be taken with or without food.

Contraindications

Hypersensitivity. Pregnancy & lactation.

Special Precautions

Intravascular vol depletion, renovascular HTN, renal impairment, kidney transplantation, HTN patients w/ type 2 DM, hyperkalemia, aortic/mitral valve stenosis, obstructive hypertrophic cardiomyopathy, primary aldosteronism.

Adverse Reactions

Dizziness, cardiac disorders, nausea/vomiting, orthostatic dizziness, orthostatic hypotension, musculoskeletal pain.

View ADR Reporting Link

Drug Interactions

Diuretics/other antihypertensive agents, K supplements, K-sparing diuretics, lithium, NSAIDs.

MIMS Class

Angiotensin II Antagonists

ATC Classification

C09CA04 - irbesartan ; Belongs to the class of angiotensin II receptor blockers (ARBs). Used in the treatment of cardiovascular disease.

Regulatory Classification

Presentation/Packing

Form

Irbeten FC tab 150 mg

Packing/Price

3 × 10's (Rp279,000/boks)

Form

Irbeten FC tab 300 mg

Packing/Price

3 × 10's (Rp333,000/boks)

Irbeten

irbesartan

Manufacturer:

Sanbe

Marketer:

Sanbe